Semi-Annual Statement Of Cash Flows

Mochida Pharmaceutical Co.,Ltd. - Filing #7584015

Concept As at
2022-09-30
2022-04-01 to
2022-09-30
As at
2022-03-31
As at
2021-09-30
2021-04-01 to
2021-09-30
As at
2021-03-31
Semi-annual statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
6,821,000,000 JPY
5,012,000,000 JPY
Interest and dividends received
172,000,000 JPY
138,000,000 JPY
Income taxes paid
-1,854,000,000 JPY
-2,251,000,000 JPY
Net cash provided by (used in) operating activities
5,174,000,000 JPY
2,891,000,000 JPY
Cash flows from investing activities
Purchase of securities
-4,500,000,000 JPY
-4,500,000,000 JPY
Proceeds from sale of securities
4,500,000,000 JPY
1,000,000,000 JPY
Proceeds from sale of investment securities
JPY
538,000,000 JPY
Other, net
-25,000,000 JPY
2,000,000 JPY
Net cash provided by (used in) investing activities
-2,139,000,000 JPY
-666,000,000 JPY
Cash flows from financing activities
Purchase of treasury shares
-937,000,000 JPY
-2,000,000 JPY
Dividends paid
-1,879,000,000 JPY
-1,912,000,000 JPY
Net cash provided by (used in) financing activities
-2,816,000,000 JPY
-1,915,000,000 JPY
Other, net
0 JPY
0 JPY
Effect of exchange rate change on cash and cash equivalents
70,000,000 JPY
2,000,000 JPY
Net increase (decrease) in cash and cash equivalents
289,000,000 JPY
312,000,000 JPY
Cash and cash equivalents
40,804,000,000 JPY
40,515,000,000 JPY
41,299,000,000 JPY
40,987,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.